CHF 5993

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CHF 5993, covering 2021-04-12 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD [Phase 3]

See pricing